FSTX Gross Margin

The Gross Margin of F-Star Therapeutics Inc (FSTX) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

FSTX Gross Margin - Peers Comparison

Ticker	Name	Value
950220.KQ	Neoimmunetech Inc	7775.20%
ABBV	Abbvie Inc	69.99%
EDSA	Edesa Biotech Inc	94.65%
BCDA	BioCardia Inc	100.00%
MRNA	Moderna Inc	70.06%
RGRX	RegeneRx Biopharmaceuticals Inc	100.00%
VCNX	Vaccinex Inc	100.00%
YTEN	Yield10 Bioscience Inc	47.14%
GILD	Gilead Sciences Inc	78.26%
REGN	Regeneron Pharmaceuticals Inc	87.01%
950200.KQ	Psomagen Inc	23.13%
ADXS	Ayala Pharmaceuticals Inc	-
AGE	AgeX Therapeutics Inc	66.67%
AMGN	Amgen Inc	61.53%
ARDS	Aridis Pharmaceuticals Inc	100.00%
VRTX	Vertex Pharmaceuticals Inc	86.11%
PTE	PolarityTE Inc	24.32%
QLGN	Qualigen Therapeutics Inc	13.65%
950160.KQ	Kolon TissueGene Inc	11.72%
HBP.TO	Helix Biopharma Corp	63.80%
MACK	Merrimack Pharmaceuticals Inc	-194.15%
CWBR	CohBar Inc	7775.20%
NPHC	Nutra Pharma Corp	8.67%
SZLS.TO	StageZero Life Sciences Ltd	-10.53%
VRDN	Viridian Therapeutics Inc	2.76%
IKT	Inhibikase Therapeutics Inc	7775.20%
MNPR	Monopar Therapeutics Inc	7775.20%
DFFN	Diffusion Pharmaceuticals Inc	100.00%
NRBO	Neurobo Pharmaceuticals Inc	7775.20%
ACHV	Achieve Life Sciences Inc	-98.76%
SYN	Synthetic Biologics Inc	85.44%
WINT	Windtree Therapeutics Inc	100.00%